Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
Authors
Keywords
-
Journal
Cancer Control
Volume 22, Issue 1, Pages 109-120
Publisher
SAGE Publications
Online
2017-08-30
DOI
10.1177/107327481502200114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, efficacy, and pharmacodynamics of the investigational agent orteronel (TAK-700) in metastatic castration-resistant prostate cancer (mCRPC): Updated data from a phase I/II study.
- (2017) David B. Agus et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.
- (2017) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
- (2017) Christopher Sweeney et al. JOURNAL OF CLINICAL ONCOLOGY
- Results from a phase 3, randomized, double-blind, multicenter, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) that has progressed during or following docetaxel-based therapy (ELM-PC 5 trial).
- (2017) Robert Dreicer et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Bone-Seeking Radionuclides in the Palliative Treatment of Patients with Painful Osteoblastic Skeletal Metastases
- (2017) Michael Tomblyn Cancer Control
- GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
- (2015) Yusuke Shiozawa et al. NEOPLASIA
- TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
- (2015) Jin Koo Kim et al. NEOPLASIA
- New agents for prostate cancer
- (2014) N. Agarwal et al. ANNALS OF ONCOLOGY
- RANK-mediated signaling network and cancer metastasis
- (2014) Gina Chia-Yi Chu et al. CANCER AND METASTASIS REVIEWS
- Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases
- (2014) Leah M. Cook et al. CANCER AND METASTASIS REVIEWS
- Immunotherapy for prostate cancer: recent developments and future challenges
- (2014) Michael T. Schweizer et al. CANCER AND METASTASIS REVIEWS
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
- (2013) S. F. Slovin et al. ANNALS OF ONCOLOGY
- Beyond abiraterone
- (2013) Álvaro Pinto CANCER BIOLOGY & THERAPY
- Castration-resistant prostate cancer: Adaptive responses in the androgen axis
- (2013) Alison Egan et al. CANCER TREATMENT REVIEWS
- A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer
- (2013) Kai-Hsiung Chang et al. CELL
- Pilot Prospective Evaluation of 99mTc-MDP Scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases
- (2013) Andrei Iagaru et al. CLINICAL NUCLEAR MEDICINE
- Tasquinimod: a novel drug in advanced prostate cancer
- (2013) Susanne Osanto et al. Future Oncology
- TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
- (2013) Paloma Bragado et al. NATURE CELL BIOLOGY
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting tumor–stromal interactions in bone metastasis
- (2013) Mark Esposito et al. PHARMACOLOGY & THERAPEUTICS
- GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation
- (2013) Russell S. Taichman et al. PLoS One
- Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets
- (2013) J. M. Drake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential use of custirsen to treat prostate cancer
- (2013) Celiste Higano OncoTargets and Therapy
- Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
- (2013) B. Zhao et al. Cancer Discovery
- Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer
- (2013) Fumio Ishizaki et al. Scientific Reports
- Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease
- (2012) Dolores Di Vizio et al. AMERICAN JOURNAL OF PATHOLOGY
- Novel and bone-targeted agents for CRPC
- (2012) K. Fizazi et al. ANNALS OF ONCOLOGY
- The prostate cancer bone marrow niche: more than just ‘fertile soil’
- (2012) Elisabeth A Pedersen et al. ASIAN JOURNAL OF ANDROLOGY
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures
- (2012) Xuan Huang et al. Journal of Hematology & Oncology
- Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
- (2012) Masuo Yamaoka et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Osteoblast-Derived Proteinase Controls Tumor Cell Survival via TGF-beta Activation in the Bone Microenvironment
- (2012) Sophie Thiolloy et al. PLoS One
- Role of denosumab in prostate cancer
- (2012) S Helo et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Immune regulation of the tumor/bone vicious cycle
- (2011) Roberta Faccio Annals of the New York Academy of Sciences
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c
- (2011) F. Saad et al. CLINICAL CANCER RESEARCH
- Current and Emerging Treatment Options for Castration-Resistant Prostate Cancer: A Focus on Immunotherapy
- (2011) Winald R. Gerritsen et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
- (2011) Roberto Pili et al. JOURNAL OF CLINICAL ONCOLOGY
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer
- (2011) K.-H. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)
- (2011) Karin Jennbacken et al. PROSTATE
- Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis
- (2010) Conor C. Lynch BONE
- Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
- (2010) J. Webber et al. CANCER RESEARCH
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2010) Kim N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Castration-Resistant Prostate Cancer: Descriptive Yet Pejorative?
- (2010) E. David Crawford et al. JOURNAL OF CLINICAL ONCOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
- (2010) Anders Olsson et al. Molecular Cancer
- Osteoclast-Derived Matrix Metalloproteinase-9 Directly Affects Angiogenesis in the Prostate Tumor-Bone Microenvironment
- (2010) A. Bruni-Cardoso et al. MOLECULAR CANCER RESEARCH
- Drug resistance in metastatic castration-resistant prostate cancer
- (2010) Bostjan Seruga et al. Nature Reviews Clinical Oncology
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
- (2009) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease
- (2009) Dolores Di Vizio et al. CANCER RESEARCH
- Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
- (2009) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets
- (2009) Kim N. Chi et al. EUROPEAN UROLOGY
- Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
- (2009) Ravi A Madan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The critical role of the bone microenvironment in cancer metastases
- (2009) Sandra Casimiro et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer
- (2008) Takuya Akashi et al. CANCER SCIENCE
- Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
- (2008) Yusuke Shiozawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases
- (2008) Martine P. Roudier et al. JOURNAL OF UROLOGY
- The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells and unwitting host to molecular parasites
- (2008) Y Shiozawa et al. LEUKEMIA
- CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro
- (2008) Y. Lu et al. MOLECULAR CANCER RESEARCH
- RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
- (2008) R. E. Miller et al. MOLECULAR CANCER THERAPEUTICS
- The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase
- (2008) Sachie Hiratsuka et al. NATURE CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started